This test is most useful if any of these apply to you.
If you have unexplained iron deficiency, stubborn anemia, or digestive symptoms after travel or life in a tropical region, a silent intestinal parasite may be the missing piece. Hookworms attach to the wall of your small intestine and feed on your blood day after day, and routine blood panels rarely tell you they are there.
This stool test looks for DNA from two groups of hookworms that infect humans, Ancylostoma and Necator. Catching them matters because chronic infection is a major cause of iron-deficiency anemia worldwide, and treatment is usually a short course of an inexpensive oral drug.
Hookworms are small blood-feeding roundworms that live in the small intestine. The two main human species are Necator americanus, which dominates globally, and Ancylostoma duodenale. A third species, Ancylostoma ceylanicum, is carried by dogs and cats and increasingly shows up in people across the Asia-Pacific region. Another dog hookworm, Ancylostoma caninum, has also been detected in human stool.
Infection usually begins when larvae in contaminated soil penetrate bare skin, most often the feet. A. duodenale can also be swallowed. The larvae travel through the body, reach the gut, grow into adult worms, latch onto the intestinal lining, and start drawing blood. Eggs then pass out in stool and continue the cycle in soil.
The central harm from hookworm is steady, low-grade intestinal bleeding. Over months and years, this depletes iron stores and drives iron-deficiency anemia. The heavier the worm burden, the more blood you lose, and the lower your iron tends to go.
Species matters here. In a study of 830 preschool children in Malawi using real-time PCR, Ancylostoma duodenale was identified as a key driver of severe anemia and bone-marrow iron deficiency, with higher infection loads tied to higher anemia rates. In earlier work on 525 schoolchildren in Zanzibar, schools where A. duodenale predominated had much worse iron status and anemia than schools where Necator americanus was the main species. A. duodenale is thought to cause roughly five times more blood loss per worm than N. americanus.
Hookworm is one of the most common human infections in the world, with hundreds of millions of people affected, particularly across Southeast Asia, sub-Saharan Africa, and parts of Central and South America. You are most likely to be exposed if you live in, travel to, or recently migrated from a tropical or subtropical region, especially if you spend time barefoot on soil, work in agriculture, or live in places with limited sanitation.
Many people with hookworm have no obvious symptoms. When symptoms appear, they often include vague abdominal pain, bloating, diarrhea, or occult (hidden) blood in stool. More dramatic presentations, including bloody diarrhea and weight loss, have been described in travelers returning with A. ceylanicum infection. Zoonotic A. caninum in humans has been linked to eosinophilic enteritis, a form of gut inflammation marked by high eosinophils (a type of white blood cell).
This is a stool-based test that looks for hookworm rather than a blood marker. The result reflects whether hookworm DNA or eggs are present in your stool, and sometimes how heavy the infection is. It is not a measurement of a substance in your bloodstream, and a positive finding means living worms are shedding eggs or DNA into your gut.
Modern molecular testing (qPCR, a lab technique that detects and counts parasite DNA) is far more sensitive than traditional stool microscopy. In rural Bangladesh, multi-parallel qPCR detected many more hookworm infections than double-slide Kato-Katz microscopy. In Malawian children, hookworm prevalence was 5.6% by microscopy versus 34.1% by PCR. In Kenyan children, microscopy was only 32% sensitive compared with qPCR for Necator americanus. Molecular testing can also tell apart species, which microscopy cannot.
Because this is a detection test rather than a number you can optimize, the main question it answers is binary: hookworm DNA is present or it is not. For people with an exposure history plus unexplained iron deficiency, anemia, persistent eosinophilia, or vague gut symptoms, a positive result can identify a treatable cause that routine blood panels will not explain on their own.
There is no standardized clinical reference interval for hookworm in the way there is for cholesterol or glucose. It is a pathogen detection test, not a quantitative biomarker. The research literature typically frames results in two categories, and some assays also estimate intensity.
| Result | What It Means |
|---|---|
| Not detected | No hookworm DNA or eggs found in this stool sample. Sensitivity is not 100%, so a single negative result in someone with high pretest suspicion may warrant repeat testing. |
| Detected | Hookworm DNA or eggs present. A species-specific result (Necator americanus, Ancylostoma duodenale, or A. ceylanicum) helps estimate blood loss risk, since A. duodenale causes more blood loss per worm. |
| Higher intensity (qPCR or egg count) | Greater worm burden is associated with more blood loss and a higher chance of iron deficiency and anemia. |
Compare your results within the same lab over time for the most meaningful trend, and interpret any molecular result alongside your symptoms, exposure history, and iron and blood count panels.
Stool testing can miss light infections. Standard microscopy (Kato-Katz) has around 63% sensitivity for hookworm with a double-slide read, and sensitivity drops further at low egg counts. That means a single negative microscopy result does not fully rule out infection, especially if your clinical picture fits.
If you are in an at-risk group and your first test is negative but symptoms or iron deficiency persist, retest using a more sensitive molecular method if you have not already. If you are treating a known infection, retest after completing therapy to confirm clearance, since cure rates with standard single-dose drugs are lower than many clinicians assume once diagnostic error is accounted for. After treatment, follow up your iron studies and blood count over the next 3 to 6 months to confirm your iron stores are recovering.
A positive result is actionable. Standard treatment is an oral anthelmintic drug, typically albendazole or mebendazole. In a Cambodian study of 1,223 people treated with a single 400 mg dose of albendazole, cure rates against hookworm ranged widely depending on baseline intensity and other factors. Multi-dose regimens and newer agents perform better. A trial of 108 schoolchildren found that mebendazole given as 100 mg twice daily for 3 days produced a cure rate of 96.1% and an egg reduction rate of 99.5% at 14 to 21 days, compared with much weaker results from a single 500 mg dose. A phase 2b trial of 293 adolescents and adults showed that a 30 mg dose of emodepside achieved 96.6% cure at 14 to 21 days versus 81.2% for single-dose albendazole, though mild side effects were more common.
Alongside treatment, order an iron panel and a complete blood count if you have not already, since chronic hookworm infection is often the hidden reason for low iron and anemia. Consider retesting stool after therapy to confirm clearance, and consider a specialist in tropical or infectious diseases if your exposure history is significant, your symptoms are severe, or repeated courses do not clear the infection.
Hookworm testing is most useful when paired with results that show its downstream effects on your body. An iron panel reveals ferritin, transferrin saturation, and total iron, which often drop in chronic hookworm infection. A complete blood count can show anemia and sometimes elevated eosinophils, a classic immune signature of parasitic infection. Multi-parasite stool panels can also detect co-infections, which were present in more than 60% of people in some endemic-area studies using qPCR versus only about 24% by microscopy.
Evidence-backed interventions that affect your Ancylostoma / Necator (Hookworm) level
Ancylostoma / Necator (Hookworm) is best interpreted alongside these tests.